title: Rituximab as an effective treatment of hyperhemolysis syndrome in sickle cell anemia.
authors.forename: Claude
authors.initials: C
authors.lastname: Bachmeyer
authors.forename: Jacqueline
authors.initials: J
authors.lastname: Maury
authors.forename: Antoine
authors.initials: A
authors.lastname: Parrot
authors.forename: Dora
authors.initials: D
authors.lastname: Bachir
authors.forename: Katia
authors.initials: K
authors.lastname: Stankovic
authors.forename: Robert
authors.initials: R
authors.lastname: Girot
authors.forename: François
authors.initials: F
authors.lastname: Lionnet
mesh_terms: D000328:Adult; D000755:Anemia, Sickle Cell / Q000188:drug therapy*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D006461:Hemolysis; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D008297:Male; D000069283:Rituximab
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab